Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease

Clinical trial NCT02101164 · WITHDRAWN

Trial details

NCT number: NCT02101164
Sponsor: Amgen
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Solid Tumor Metastatic Bone Disease

Start date: 2014-11-01
Primary completion: 2014-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.